Arkolith/Insider Trading/SPRO/Form 4

Rajavelu Esther

CFO & CBOSpero Therapeutics, Inc. (SPRO) · full profile →Form 4 · filed Nov 12, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$53K
Net Open-Market Flow
-$53K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 8, 2024Sell(S)17K$1.30$22K379K
Nov 7, 2024Sell(S)23K$1.31$31K397K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-125339) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML